Opioid Overdose Risk in Patients Returning to the Emergency Department for Pain.
Emergency Department
Opioid
Overdose
RIOSORD
Journal
Pain medicine (Malden, Mass.)
ISSN: 1526-4637
Titre abrégé: Pain Med
Pays: England
ID NLM: 100894201
Informations de publication
Date de publication:
08 09 2021
08 09 2021
Historique:
pubmed:
10
2
2021
medline:
9
10
2021
entrez:
9
2
2021
Statut:
ppublish
Résumé
Using the Risk Index for Overdose or Serious Opioid-induced Respiratory Depression (CIP-RIOSORD) in patients returning to the emergency department (ED) for pain and discharged with an opioid prescription, we assessed overall opioid overdose risk and compared risk in opioid naive patients to those who are non-opioid naive. This was a secondary analysis from a prospective observational study of patients ≥ 18 years old returning to the ED within 30 days. Data were collected from patient interviews and chart reviews. Patients were categorized as Group 1 (not using prescription opioids) or Group 2 (consuming prescription opioids). Statistical analyses were performed using Fisher's exact and Wilcoxon's rank sum tests. Risk class and probability of overdose was determined using Risk Index for Overdose or Serious Opioid-induced Respiratory Depression (CIP-RIOSORD). Of the 389 enrollees who returned to the ED due to pain within 30 days of an initial visit, 67 (17%) were prescribed opioids. The majority of these patients were in Group 1 (60%). Both Group 1 (n = 40) and Group 2 (n = 27) held an average CIP-RIOSORD risk class of 3. Race significantly differed between groups; the majority of Group 1 self-identified as African American (80%) (P = .0267). There were no differences in age, gender, or CIP-RIOSORD risk class between groups. However, Group 2 had nearly double the number of predictive factors (median = 1.93) as Group 1 (median = 1.18) (P = .0267). A substantial proportion of patients (25%) were high risk for opioid overdose. CIP-RIOSORD may prove beneficial in risk stratification of patients discharged with prescription opioids from the ED.
Identifiants
pubmed: 33560418
pii: 6131685
doi: 10.1093/pm/pnab047
pmc: PMC8633658
doi:
Types de publication
Journal Article
Observational Study
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2100-2105Subventions
Organisme : NIA NIH HHS
ID : F33 AG005654
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000064
Pays : United States
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of the American Academy of Pain Medicine.All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
MMWR Morb Mortal Wkly Rep. 2020 Mar 20;69(11):298-302
pubmed: 32191686
Pain Med. 2018 Jan 1;19(1):68-78
pubmed: 28340046
Pain Ther. 2017 Dec;6(2):193-202
pubmed: 29127600
Drug Alcohol Depend. 2019 Dec 1;205:107636
pubmed: 31704377
Pain Med. 2020 Nov 1;21(11):2748-2756
pubmed: 32875332
Am J Emerg Med. 2002 May;20(3):165-9
pubmed: 11992334
Res Social Adm Pharm. 2021 May;17(5):1017-1020
pubmed: 32980236
MMWR Morb Mortal Wkly Rep. 2020 Mar 20;69(11):290-297
pubmed: 32191688
Pain Med. 2012 Feb;13(2):150-74
pubmed: 22239747
Pain Med. 2015 Aug;16(8):1566-79
pubmed: 26077738
Pain Med. 2020 Oct 1;21(10):2219-2228
pubmed: 32191316
Ann Pharmacother. 2018 Apr;52(4):325-331
pubmed: 29086587